Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

NULL
   
  • Closing Price Chg:
      18.00p
  • 52 Week High: NUL
  • 52 Week Low: 233.00p
  • Currency: UK Pounds
  • Shares Issued: 106.14m
  • Volume: 0
  • RiskGrade: 125
  • Beta: 0.02

Latest ShareCast News

Oxford Biomedica flags sharp rise in first-half revenue

By Josh White

Date: Monday 28 Jul 2025

(Sharecast News) - Oxford Biomedica reported a sharp rise in first-half revenue and strong commercial momentum on Monday, as it reiterated its full-year guidance and pointed to growing demand across its cell and gene therapy manufacturing platforms.

OXB ShareCast News

Oxford Biomedica acquires last 10pc stake in US ... 23-Jun-2025 ShareCast
Oxford Biomedica reports first-half revenue growth 23-Sep-2024 ShareCast
Oxford Biomedica still expecting small loss afte... 08-Aug-2024 ShareCast
Oxford Biomedica appoints new finance chief 17-Jul-2024 ShareCast
Oxford Biomedica confident as it moves away from... 29-Apr-2024 ShareCast

OXB Regulatory News

Half Year Trading Update 28-Jul-2025 07:00 RNS
Director Declaration 02-Jul-2025 07:00 RNS
Block listing Interim Review 01-Jul-2025 07:00 RNS
Total Voting Rights 01-Jul-2025 07:00 RNS
OXB completes acquisition of US subsidiary 23-Jun-2025 07:00 RNS

OXB Newspaper Links

Need to know: Opec cuts forecast ... Tesco cuts ... 16-Aug-2008 Times
Need to know 10-May-2008 Times
DSG International may be losing its spark 12-Feb-2008 Telegraph
Oxford BioMedica clinches $690m licensing deal f... 29-Mar-2007 The Independent
Oxford Biomedica seals €518m deal with Sanofi ov... 29-Mar-2007 Times

OXB Tips & Analysis

FTSE 100 latest: Oil falls take shares lower 06-Jul-2009 Daily Mail
The Investment Column: Oxford Biomedica 11-Mar-2008 The Independent
Jetion could benefit from Spanish election 11-Mar-2008 Times
The Week Ahead: Kazakh and Tate & Lyle head for ... 10-Mar-2008 The Independent
Market Report: Prudential driven up on Chinese b... 06-Mar-2008 The Independent

OXB News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price NULL
Closing Price Change 18.00p
% Change 0.00 %
52 Week High NUL
52 Week Low 233.00p
Volume 0
Shares Issued 106.14m
Beta 0.02
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
32.52% below the market average32.52% below the market average32.52% below the market average32.52% below the market average32.52% below the market average
20.93% above the sector average20.93% above the sector average20.93% above the sector average20.93% above the sector average20.93% above the sector average
Price Trend
53.87% above the market average53.87% above the market average53.87% above the market average53.87% above the market average53.87% above the market average
77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average77.78% above the sector average
Income Not Available
Growth
4.25% above the market average4.25% above the market average4.25% above the market average4.25% above the market average4.25% above the market average
20% below the sector average20% below the sector average20% below the sector average20% below the sector average20% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 4
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for --2025

Time Volume / Share Price
0 @ 0.000p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page